Economy

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Moving Today - Down by 11.54%

The stock was purchased at an average cost of $3.00 per share, with a total value of $45,000.00. In the latest earnings report the EPS was $-1.10 and is expected to be $-1.12 for the current year with 45,380,000 shares presently outstanding. Johnson & Johnson now has $365.35B valuation.

The stock increased 0.40% or $0.03 during the last trading session, reaching $7.59. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since October 17, 2016 and is uptrending. It has underperformed by 14.60% the S&P500.

Analysts recommendation for AcelRx Pharmaceuticals, Inc. The stock now has an average rating of "Hold" and a consensus target price of $7.67. Roth Capital has "Buy" rating and $12.5000 target. The stock has "Buy" rating by Seaport Global on Friday, May 6. TH Capital has "Buy" rating and $15 target.

AcelRx Pharmaceuticals, Inc. (ACRX) reported sales (ttm) of 15.6 Million, whereas, 6 number of analysts estimated the mean sale of 2.84 million. Royal Bank Of Canada now has an outperform rating on the stock. On Tuesday, May 3 the stock rating was maintained by H.C. Wainwright with "Buy". As per Monday, October 5, the company rating was maintained by TH Capital.

TRADEMARK VIOLATION WARNING: "AcelRx Pharmaceuticals' (NASDAQ:ACRX) Buy Rating Reaffirmed at HC Wainwright" was first published by TrueBlueTribune and is owned by of TrueBlueTribune. Acelrx Pharmaceutica (NASDAQ:ACRX) has trailing twelve month Return on Assets of -53.3%, which is key indicator of how profitable a company is relative to its total assets. Therefore 32% are positive. Zacks Investment Research raised AcelRx Pharmaceuticals from a sell rating to a hold rating in a research report on Friday, August 4th. As per Wednesday, September 20, the company rating was downgraded by Goldman Sachs. (NYSE:UPS) rating on Tuesday, December 13. The VC1 of AcelRx Pharmaceuticals, Inc. On Thursday, August 31 the stock rating was maintained by UBS with "Buy".

Not surprisingly, $1.70 is the stock's low for the year. The price to earnings ratio for AcelRx Pharmaceuticals, Inc. 148,309 are held by Lmr Limited Liability Partnership. 105 funds opened positions while 667 raised stakes.

Shares of Tesla, Inc. Salem Invest Counselors invested in 3,435 shares. 30,359 were accumulated by Guardian Investment Management. Fincl Bank Of America De invested in 14,964 shares. Bnp Paribas Arbitrage owns 8 shares. Hbk LP owns 49,349 shares.

Raffi Asadorian, CFO reported the purchase of 7,000 shares. Ing Groep Nv, Netherlands-based fund reported 39,000 shares. Horrell Mgmt owns 27,941 shares for 1.82% of their portfolio. Winslow Evans And Crocker stated it has 18,644 shares. Its down 13.86% from 4.66 million shares previously. Art Ltd Liability Corp holds 23,418 shares or 0% of its portfolio.

Brokerage houses, on average, are recommending investors to hold Tesla, Inc. Netapp Inc (NASDAQ:NTAP) was reduced too. Trading volume was up 1,651.63% over the stocks average daily volume. It is now trading 3.62% off that level. Creative Planning holds 0% in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) or 17,700 shares. It has underperformed by 30.94% the S&P500.

03/14/2017 - AcelRx Pharmaceuticals, Inc. had its "hold" rating reiterated by analysts at Stifel Nicolaus. This is helpful in determining how the market values the company compared to it's actual worth. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. It now has negative earnings. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain.

Investors sentiment increased to 1.05 in Q2 2017. Its down 0.25, from 1 in 2017Q1. Meeder Asset Incorporated holds 1,673 shares. Geode Cap Limited stated it has 175,262 shares or 0% of all its holdings. AcelRx Pharmaceuticals traded as low as $1.90 and last traded at $1.93, with a volume of 3,922,805 shares. Deutsche Fincl Bank Ag reported 293,770 shares stake. Da Davidson & Company reported 61,900 shares. In looking the SMA 200 we see that the stock has seen a -28.14%.The Company's net profit margin for the 12 months at -. Joel Isaacson & invested in 0.03% or 70,660 shares.

03/03/2017 - AcelRx Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at RBC Capital. Manufacturers Life Ins Com The owns 2,077 shares for 0% of their portfolio.



Like this

Latest


18 October 2017
World's first floating windfarm opens off Scottish coast
The 172-metre turbines are positioned in water depths of up to 129m, however it is said they can operate in depths of 800m. As it is still early for floating wind projects, the technology can't compete with conventional offshore wind's cost.

18 October 2017
Dynegy Inc. (NYSE:DYN) Under Analyst Spotlight
Solus Alternative Asset Limited Partnership has 3.02 million shares for 5.16% of their portfolio. (NYSE:DYN) for 7.03M shares. Stone Run Cap Ltd Com holds 0.3% or 3,788 shares in its portfolio. (NYSE:DYN) for 78,292 shares. (NASDAQ:AAPL).

18 October 2017
Verizon Communications Inc. (NYSE:VZ) Under Analyst Spotlight
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Week Herald and is the sole property of of Week Herald. Blackstone Group Lp sold 2.79 million shares as the company's stock declined 19.52% while stock markets rallied. (NYSE:VZ).

18 October 2017
Manchester United scout Aarón Martin as Mourinho wants a left-back
It's claimed the Spanish outfit are increasingly resigned to losing the Spain Under-21 defender in the January transfer window. And Red Devils scouts were in attendance as the youngster played in Friday's 0-0 draw with Levante , according to ESPN .

18 October 2017
Cassini Just Solved the Mystery of What Saturn's Rings Are Made Of
The findings were presented at the American Astronomical Society's Division of Planetary Sciences meeting in Utah on October 16. Cassini had been probing Saturn for years but scientists have now begun combing through the data collected.

18 October 2017
Intel aims to conquer AI with the Nervana processor
Neural network computations on a single chip are largely constrained by power and memory bandwidth. Intel has announced what it describes as the "industry's first neural network processor".

18 October 2017
BHP Billiton plc (BLT) Trading 1.4% Higher Following Analyst Upgrade
Lafemina now forecasts that the mining company will earn $2.87 per share for the year, up from their previous estimate of $2.46. As of the end of the quarter Cutler Group LP had disposed of a total of 5,876 shares trimming its position 96.2%.

18 October 2017
AFC West standings: Chiefs can gain significant ground on Thursday
That one game aside however, Oakland isn't Pittsburgh and the Chiefs still remain undefeated against the AFC West division. Thus, the Raiders have a bit more at stake when the Chiefs and Raiders suit up to play each other on Thursday night.

18 October 2017
Nicki Minaj Covers 'The Greats' Issue of T Magazine
Recently, XXL included her in the list of hip hop artists who shaped the industry, and she was the only female on the list. She added, "So I "REINTRODUCED" the "successful" female rapper back to POP CULTURE".

18 October 2017
Liberum Capital Downgrades FlyBe (LON:FLYB); Energy Recovery Has 1 Sentiment
Over the last 30 and 90 trading days the company share price has increased 127.5 points and increased 173 points respectively. Barclays Capital's target would suggest a potential upside of 14.21% from the company's previous stock close.



Recommended